EMEA-000461-PIP02-11-M04
Key facts
| Invented name |
Cerdelga
|
| Active substance |
Eliglustat (tartrate)
|
| Therapeutic area |
Other
|
| Decision number |
P/0385/2021
|
| PIP number |
EMEA-000461-PIP02-11-M04
|
| Pharmaceutical form(s) |
Capsule, hard
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Sanofi B.V.
E-mail: eumedinfo.GZ@sanofi.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|